CG Oncology (CGON) Gross Margin (2024 - 2026)
CG Oncology's (CGON) quarterly Gross Margin came in at 173.5% in Q1 2026, down 27350.0% YoY from N/an in Q1 2025, and down 438.59% on a QoQ basis from 32.21% in Q4 2025.
CG Oncology (CGON) Gross Margin (2024 - 2026) Analysis & Trends
CG Oncology (CGON) has 3 years of Gross Margin data on file, last reported at 173.5% in Q1 2026.
- Quarterly Gross Margin fell 27350.0% year-over-year to 173.5% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 49.02% (changed N/A YoY) and the FY2025 annual result came in at 15.02%, down 11502.0% from the prior year.
- Gross Margin declined to 173.5% in Q1 2026, from 32.21% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 100.0% in Q3 2024 to a low of 173.5% in Q1 2026.
- A 3-year average of 16.6% and a median of 52.67% in 2024 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2025 — Gross Margin tumbled 9466 bps — and 2026, when it tumbled 27350 bps.
- Tracing CGON's Gross Margin over 3 years: stood at 100.0% in 2024, then slumped by 132 bps to 32.21% in 2025, then plunged by 439 bps to 173.5% in 2026.
- The last three Gross Margin figures came in at 173.5% (Q1 2026), 32.21% (Q4 2025), and 5.34% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 90.68% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 89.76% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 60,631,834.75% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 76.90% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 84.20% |
| 10 | CG Oncology | 6.63 Bn | 6.63 Bn | -2.77 Mn | -239.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -239.24% |
| Mar 31, 2026 | -173.50% |
| Dec 31, 2025 | -32.21% |
| Sep 30, 2025 | 5.34% |
| Mar 31, 2025 | 100.00% |
| Dec 31, 2024 | 100.00% |
| Sep 30, 2024 | 100.00% |